about
Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion.Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion.Treatment (biotherapy excluded) of psoriatic arthritis: an appraisal of methodological quality of international guidelines.Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review.Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus.Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis.Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.[Drug hypersensitivity: definitions and mechanisms].Spontaneous odontoid fracture on a tophus responsible for spinal cord compression: a case report.Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.sQUIZ your knowledge! Persistent facial plaques.Management of psoriatic arthritis among cutaneous psoriasis patients: from pathogenesis to therapy.DeRmpath & Clinic: Regressive melanoma associated with vitiligo-like depigmentation.Dermpath & Clinic: Zosteriform Lichen aureus.DeRmpath & Clinic Granular cell tumor of the vulva.Residents'corner April 2015. DeRmpath & Clinic - Idiopathic Atrophoderma of Pasini and Pierini.Residents'corner April 2015. Editorial: What's new this month?Editorial: What's new this month?Residents'corner January/February 2016. Editorial: What's new this month?7th Drug hypersensitivity meeting: part two.Tumor necrosis factor-alpha inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: a multicenter retrospective studyImage Gallery: Pyostomatitis vegetans of the tongue[Pectoral nodule: nodular melanoma]Residents' corner June 2015. Editorial: What's new this month?Vemurafenib-induced panniculitisResidents' corner February 2015. Editorial: What's new this month?Residents'corner October 2015. Editorial: What's new this month ?Application of C4d Immunohistochemistry on Routinely Processed Tissue Sections for the Diagnosis of Autoimmune Bullous DermatosesEditorial: What's new this month?Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNFα blockerEditorial: What's new this month?Editorial: What's new this month?DeRmpath & Clinic: OnychopapillomasQUIZ your knowledgeǃ: A recent red lesion on the forearmEditorial: What's new this month?Dermpath & Clinic: Drug-induced Sweet syndrome[Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis]Residents'corner March-April 2016. Editorial: What's new this month?Dermpath & Clinic: Pruritic erythematous lesions on the trunk and legsAre there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study
P50
Q35199592-169CB4A0-D394-457B-ADF4-CE6B50D6F154Q35199597-0FD5ECC2-A584-4422-B2CE-8602C9C0AEF6Q35199602-AC582C75-F703-4C9C-BF5D-EE71BF1E5E7BQ38225380-81FE06F2-E85A-446C-A5F8-1036DBA53859Q38225381-8B8F8975-20FC-4CBA-A807-533145B05D2FQ38520742-336C25EF-9F8D-47B7-A0C9-00CF7AAA823FQ40759960-04342118-EEFD-4CAB-8E9B-91BD456FBCE2Q41087384-161A3707-959E-4647-A2D9-6CDEE1140216Q45909248-84F29FBE-405D-424E-A833-EAE4EB2D84DEQ48260654-2CADCC4E-1B81-4536-9B32-F631D773D399Q50134241-0192E9FE-6A39-40C0-9209-A0DA09542112Q50629677-013DA6D8-1B2B-4DC8-86CB-EAA2F5FF1668Q53048352-5BDDEC97-8FE7-4FEB-8342-83B1E355F1D0Q53094363-936B09A4-0672-4715-BE75-8941CF652BE7Q53179683-F37FDDE0-13BA-4606-BAD1-6CD275D14D55Q53468136-0C21F23C-B4F5-4149-B7F3-D997F2380875Q53468140-985C93F0-D105-4205-859E-2AC0044D6EFAQ53664441-FE157A06-8EB1-459F-87FE-4055278E77C8Q53791891-C059C195-B9CB-439B-9232-243EABDABB77Q54526061-6DF2ED34-BDDD-49EB-94FC-D42DEA055DF8Q57813561-34879AD1-BFCE-4C22-A007-9454AEB817C5Q58545428-898DBB1F-5B1C-4955-AF37-0EC54E712A18Q84112781-4CEAA44A-CA25-4C81-82CD-EF187ABED637Q86289382-969D8BE9-81B0-42D1-8208-2F28E45A9FD2Q86559937-8B88C2A9-EA77-41F1-848E-A1245A7903C0Q86953814-01C10DBD-909C-42CE-8BEA-973CF947ECBEQ86955460-07E2F881-C60A-420D-8F4A-D9A5DBD5BFCAQ86964432-1F09170B-731F-436F-BA53-DBBD6D4C73CBQ87257332-E083AE68-98B7-41E2-947E-5E82C1A559E7Q87342544-4B554653-7BE9-4E7A-B425-C00FFCCF39D8Q87720131-02EEC260-AB4E-4F97-863B-9DAA81DAEBB9Q88135138-777283CF-1288-46E8-966D-C580CBC31707Q88450330-6FFAC61D-703E-4A77-8472-6DCC8FAD7D6AQ88561062-3B7EC255-BE46-408A-A580-5B7AB4CA314EQ88641984-E0012A6A-D9FD-4737-91F0-3319C162226CQ88836099-60032CE6-BFCF-48FB-9A6D-E33C5D7CA265Q89184421-69309311-85B6-4C3C-B2F9-307FF3BDAA52Q89288468-4A24176F-FE34-4840-9350-AAD09218B3A8Q90363523-F0A62F74-49CF-4EB5-A488-3954C640FE28Q91581360-96577F2F-5508-4E56-98D1-51A2D1689329
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
A-P Villani
@en
A-P Villani
@nl
type
label
A-P Villani
@en
A-P Villani
@nl
prefLabel
A-P Villani
@en
A-P Villani
@nl
P31
P496
0000-0002-3067-807X